StockWatch
·

Tarsons Products Ltd

BSE: 543399

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
92.90
-11.2%+22.5%
Expenditure
91.98
-4.9%+29.4%
Net Profit
0.68
-87.6%-81.0%
OPM %
28.06%
-5.70pp-3.13pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0029.2858.5687.84117.12Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Revenue Beats, Profit Misses — Capex Year Underway

capex burden · revenue growth · margin compression

Result verdictFollow-upQ1 FY2717 Aug 20266 minPharma & Healthcare

Growth strong, profit misses — capex drag and raw material headwind

revenue momentum · margin compression · capex ramp

TranscriptDeep diveQ1 FY2717 Aug 20266 minPharma & Healthcare

Tarsons swings to ₹1.4 Cr consolidated loss in Q1 FY27 despite 20.7% YoY revenue growth

lab plasticware · margin compression · consolidated loss

ResultsQ1 FY2710 Aug 20263 minPharma & Healthcare
Latest

Corporate Events

Board MeetingTARSONS
2026
12Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingTARSONS
2026
24Sep

Board Meeting

The 43rd Annual General Meeting (AGM) of the Company will be…

BSE Filing ↗
Board MeetingTARSONS
2026
10Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingTARSONS
2026
22May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing ↗
DividendTARSONS
2024
20Sep

₹2 / share

BSE Filing ↗
Board MeetingTARSONS
2024
14Aug

Board Meeting

Consider and approve Unaudited Financial Results

BSE Filing ↗
Board MeetingTARSONS
2024
30May

Board Meeting

To consider and approve Audited Financial Results for the fo…

BSE Filing ↗
Board MeetingTARSONS
2023
11Nov

Board Meeting

consider and approve Unaudited Financial Results for quarter…

BSE Filing ↗
Board MeetingTARSONS
2023
11Aug

Board Meeting

Consider and approve Unaudited Financial Results for quarter…

BSE Filing ↗